rabeprazole has been researched along with Chagas Disease in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
García-Torres, I | 1 |
De la Mora-De la Mora, I | 1 |
López-Velázquez, G | 1 |
Cabrera, N | 1 |
Flores-López, LA | 1 |
Becker, I | 1 |
Herrera-López, J | 1 |
Hernández, R | 1 |
Pérez-Montfort, R | 1 |
Enríquez-Flores, S | 1 |
1 other study available for rabeprazole and Chagas Disease
Article | Year |
---|---|
Repurposing of rabeprazole as an anti-
Topics: Chagas Disease; Drug Repositioning; Humans; Rabeprazole; Triose-Phosphate Isomerase; Trypanocidal Ag | 2023 |